Inventor · disambiguated record
Christian Frauendorf
Also filed as: FRAUENDORF CHRISTIAN
12 granted patents·8 pending applications·46 citations·filing 2001–2024
88Inventor score
Top patents by PatentIndex Score
20 records- 0195US11015198B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted May 25, 2021·14 cites·7 claims
- 0292US11499153B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2021·Granted Nov 15, 2022·2 cites·28 claims
- 0392US11319537B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2018·Granted May 3, 2022·18 cites·15 claims
- 0490US11174483B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Nov 16, 2021·6 cites·19 claims
- 0588US12084656B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Granted Sep 10, 2024·1 cites·14 claims
- 0688US12054717B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 0784US10913945B2Nucleic acid linked to a trivalent glycoconjugateSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Feb 9, 2021·2 cites·3 claims
- 0883US2025043288A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0982US11414660B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Aug 16, 2022·2 cites·20 claims
- 1080US2024327843A1Nucleic acids for inhibiting expression of lpa in a cellSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 1176US2024200071A1Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkagesSILENCE THERAPEUTICS GMBH·Filed 2023·Application pending·0 cites
- 1268US11987794B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 1364US11912993B2Nucleic acid linked to a trivalent glycoconjugateSILENCE THERAPEUTICS GMBH·Filed 2020·Granted Feb 27, 2024·0 cites·13 claims
- 1463US2022002722A1Nucleic acids for inhibiting expression of lpa in a cellSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1562US2022025377A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 1661US11873489B2Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkagesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Jan 16, 2024·0 cites·14 claims
- 1750US11299738B2Further novel oligonucleotide-ligand conjugatesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Apr 12, 2022·0 cites·23 claims
- 1847US2022017899A1Nucleic acids for inhibiting expression of c3 in a cellSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1947US2003219422A1Allosteric ribozymes and uses thereofNOXXON PHARMA AG·Filed 2002·Application pending·0 cites
- 2035US2005208487A1Immobilized nuckeic acids and uses thereofBURMEISTER JENS·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Frauendorf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →